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Abstract
Acute kidney injury (AKI) is a common complication in criti-
cally ill patients, especially among septic patients. Sepsis and 
hypovolemia are the 2 most frequent etiologies of AKI in in-
tensive care units and frequently coexist in critically ill pa-
tients. Effective fluid resuscitation is crucial for the stabiliza-
tion of sepsis-induced tissue hypoperfusion or septic shock. 
However, the lack of a goal-directed therapy targeting kid-
ney oxygenation prevents from optimization of the fluid 
therapy with regard to improvement of renal oxygen deliv-
ery and extraction. Similarly, fluid administration as all thera-
peutic actions carries adverse effects such as the activation 
of cytokines, disruption of the capillary glycocalyx, and ad-
verse effects on kidney metabolism and oxygenation. More-
over, a positive fluid balance is associated with an increased 
risk of AKI and is a negative predictor for recovery of renal 
function. The role of fluid resuscitation on kidney injury 
stems from the high renal vulnerability to hypoxemic injury. 
Indeed, fluids have a poor oxygen solubility and hemodilu-
tion decreases blood viscosity both promoting intrarenal 
shunting and heterogeneity with a decreased capillary den-
sity and enhanced intrarenal cortex and medullary hypoxia. 
The development of physiological biomarkers that are able 
to detect the early development of AKI specifically aimed at 
the identification of renal microcirculatory dysfunctions 
should form a valuable contribution to monitoring thera-
peutic modalities. © 2019 The Author(s) 
Published by S. Karger AG, Basel
Introduction
Nearly 2 centuries ago, oliguria was recognized as a sign 
of renal failure and serum creatinine as marker of renal 
function. Despite that, their standardization of acute kid-
ney injury (AKI) using serum creatinine and urinary out-
put did not occur until the description of the Risk, Injury, 
Failure, Loss, End-stage criteria in 2004, where a urinary 
output of < 0.5 mL/kg/h for > 6 h was introduced as an al-
ternative criterion to a rise in serum creatinine by 1.5-fold 
from baseline. This definition has evolved to the AKI Net-
work classification in 2007 and to the Kidney Disease Im-
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proving Global Outcomes classification in 2012. The inci-
dence of AKI varies between one-third to two-thirds of 
patients admitted to intensive care units (ICUs) when de-
fined by the sensitive Risk, Injury, Failure, Loss, End-stage, 
AKI Network, or Kidney Disease Improving Global Out-
comes criteria and it is increasing over time as is the use of 
renal replacement therapy (RRT) [1]. Variation in AKI in-
cidence and severity reported in critically ill patients may 
stem from baseline patients’ characteristics, attitudes to-
wards initiation of RRT, more consistent recording in ad-
ministrative databases and the length of the observation 
period. The pathophysiology of AKI in septic patients is 
likely to be multifactorial involving hemodynamic and 
microcirculatory mechanisms that lead to impaired tissue 
oxygenation. However, the lack of accurate and sensitive 
diagnostic criteria for metabolic renal impairment ham-
pers the prevention of AKI in ICU. Furthermore, the op-
timization of kidney perfusion is prevented by the lack of 
a goal-directed therapy for kidney oxygenation.
The aim of this brief review is to examine the rationale 
for actual fluid management in septic patients and iden-
tify some iatrogenic mechanisms that may contribute to 
AKI development.
AKI in ICUs
Among critically ill patients AKI may already be pres-
ent at ICU admission (community-acquired) or develop 
during hospital stay (hospital-acquired). This second 
type has been shown to be associated with worse progno-
sis and its pathogenesis is most often iatrogenic. The 2 
most frequent etiologies of AKI in ICU are sepsis and hy-
povolemia and frequently the 2 are associated. Volume 
depletion is a very frequent situation in ICU patients and 
is a well-known risk factor for AKI. On the one hand, the 
correction of volume deficit will prevent the extension of 
kidney injury and facilitate renal function recovery. On 
the other hand, fluid administration may lead to adverse 
events including tissue edema and anemia. Moreover, the 
primary pathophysiologic phenomenon in septic shock is 
vasoplegia, causing a state of hypotension not corrected 
by fluid administration but rather by vasoconstricting 
agents. Establishing the right fluid volume to be adminis-
tered in septic patients is also a challenge. Finally, hemo-
dynamic monitoring helps physicians to identify patients 
likely to be fluid responsiveness but seems to be insuffi-
cient to minimize the development of AKI and not pro-
vide information about the response of the renal micro-
circulation to fluid administration. 
Kidney Metabolism
Considering its multiple etiologies, variable pathogen-
esis and diverse outcomes, AKI may be described as a 
syndrome characterized by a rapid deterioration of kid-
ney function occurring within hours or days that may 
lead to the need of temporary or chronic RRT. The high-
ly complex architecture of the renal microvasculature, the 
need to meet a high energy demand, and the fact that the 
kidney is borderline ischemic make the kidney a highly 
vulnerable organ to hypoxemic injury. In particular, ap-
proximately 90% of kidney oxygen requirement seems to 
be used for ATP production needed for Na/K pump func-
tion. The mechanism accounting for the larger part of the 
oxygen consumption is the tubular sodium reabsorption, 
that is already exposed to ischemic damage in critically ill 
patients. Under normal, steady-state conditions, oxygen 
supply to the renal tissues is well regulated; however, un-
der septic conditions, the delicate balance between oxy-
gen supply and demand is disturbed due to renal micro-
vasculature dysfunction [2]. The reduction in glomerular 
filtration rate secondary to hypotension related to hypo-
volemia and decreased cardiac output are the mecha-
nisms considered to be responsible for oliguria and raised 
serum creatinine. However, in the early phase of sepsis, 
where fluids are being administered during the develop-
ment or established AKI, an increased cardiac output un-
derlies the development of a “hyperdynamic state”.
Fluid Resuscitation and the Kidney
The need for prompt fluid resuscitation in the process 
of restoring euvolemia and systemic hemodynamics in 
septic patients is well established. However, a common re-
sponse to an episode of hypotension in ICU is, neverthe-
less, the administration of fluids despite growing evidence 
showing that the cardiac output does not always increase 
in most critically ill patients when challenged with a fluid 
bolus according to fluid responsiveness criteria. In addi-
tion, the exact amount and precise timing of tapering such 
resuscitation is not established. Specifically, with regard to 
AKI, fluid resuscitation is considered a preventive mea-
sure based on the theory that restoration of circulating vol-
ume will improve renal perfusion. Pranskunas et al. [3] 
have examined changes in sublingual microcirculation 
before and after fluid administration in patients with clin-
ical signs of impaired organ perfusion. They found that 
fluid administration was able to improve microcirculatory 
flow in patients with impairment at the baseline but with 
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no impact on capillary density both in patients with and 
without microcirculatory flow impairment at the baseline. 
Accordingly, signs of impaired organ perfusion improved 
only among those patients with microcirculatory dysfunc-
tion at baseline but not in those with normal perfusion. 
These changes were independent of effects of fluid resus-
citation on stroke volume which increased in all subjects. 
In other studies, the improvement of hemodynamic mac-
rovascular parameters resulted in restoration, decreased 
or even unaffected cortical renal perfusion during septic 
shock [4]. Furthermore, it should be considered that fluids 
are not different from drugs and carry side effects such as 
the activation of cytokines, shedding of the capillary gly-
cocalyx, and adversely affecting the capacity of the kidney 
to adequately filter excess fluid and nitrogenous waste. 
The recently released “hour-1 bundle” confirms that fluid 
resuscitation should be performed in septic patients with 
hypotension or lactate ≥ 4 mmol/L with 30 mL/kg of crys-
talloids previously reported in the “3-h bundle” [5]. De-
spite being reported as strong recommendation, the qual-
ity of reported evidence is low and not supported by clini-
cal studies. On the contrary, in adult patients admitted to 
the ICU with sepsis, a positive fluid balance after the first 
day was associated with an increased risk of AKI [6]. Not 
only does fluid overload increase mortality, but excess flu-
id has also been showed to be a negative predictor for re-
covery of renal function [1]. However, it is impossible to 
account for all potential confounders and it is difficult to 
prove whether fluid overload directly causes adverse out-
comes or, vice versa, where critical illness itself is respon-
sible for fluid overload. Fluid administration causes 
 increased workload for the kidneys because of increased 
filtration of sodium chloride leading to increased reab-
sorption activity, and increased oxygen consumption of 
the tubular cells. Finally, although current international 
guidelines from the Surviving Sepsis Campaign recom-
mend crystalloids for initial resuscitation and subsequent 
volume replacement with albumin “when patients require 
substantial amount of crystalloids”, the debate on which 
type of fluid to use in the resuscitation phase is still open. 
A recent meta-analysis including 55 randomized clinical 
trials reported that crystalloids were less effective than col-
loids in stabilizing resuscitation endpoints such as mean 
arterial pressure, cardiac index, and central venous pres-
sure [7]. Moreover, although the primary outcome in the 
CRISTAL trial showed a not significant lower 30-day mor-
tality in the colloids group in comparison to the crystalloid 
group (p value 0.26), 90-day mortality was significantly 
lower (p value 0.03) when colloids were used for fluid re-
suscitation [8]. Inconsistences with studies reporting dif-
ferent findings may stem from different patients’ volemic 
state at the time of randomization [9]. Despite the in-
creased use of balanced solutions, NaCl 0.9% is probably 
still the most used crystalloid solution for fluid manage-
ment [10]. This is despite the well-documented adverse 
effects of the use of NaCl 0.9% [11]. Finally, existing evi-
dence supporting albumin use in patients with septic 
shock comes from the ALBIOS study where albumin ad-
ministration was used to replenish albumin instead of us-
ing it for treating hypovolemia in a similar manner to the 
manner in which synthetic colloids are used [12].
AKI from a Microcirculatory Point of View 
Microcirculatory dysfunction in sepsis is characterized 
by heterogeneous abnormalities in renal blood flow in 
which some capillaries are under-perfused, while others 
have normal or abnormally high blood flow. Although the 
issue is still a controversy, histopathological studies have 
shown that sepsis or septic shock can lead to areas of isch-
emia of tubular cells mainly located at the cortex micro-
circulatory level because of hypoxia and the overproduc-
tion of reactive oxygen and nitrogen species and cytokines 
[13]. These heterogeneous conditions associated with 
sepsis can also be the result of therapy such as the admin-
istration of fluids. Thus, although fluid resuscitation can 
normalize the renal arterial flow, it can cause heteroge-
neous microcirculatory flow in the renal cortex, resulting 
in a pattern of hypoxic areas next to normoxic areas. As a 
consequence, hypoxia contributes to renal oxygen extrac-
tion dysfunction and production of reactive oxygen spe-
cies that can further contribute to kidney injury [14]. In-
deed, findings from Legrand et al. [15] suggested that half 
of the oliguric patients in the ICUs are not renal respond-
ers to fluid challenge although they show a macrohemo-
dynamic response. Additionally, sepsis-induced endothe-
lial dysfunctions such as microvascular thrombosis, en-
dothelial injury, and shedding of the endothelial 
glycocalyx further promote abnormal microcirculation, 
areas of hypoxemia, and increased capillary leak decreas-
ing the potential benefits of fluids. In addition, fluid ad-
ministration itself may increase inflammation contribut-
ing to endothelial degradation promoting rolling and ad-
hesion of leucocytes and increased platelet adhesion. Yet, 
hemodilution caused by fluids leading to anemia is prob-
ably the most deleterious effect associated with fluid ad-
ministration. Indeed, besides the poor oxygen solubility 
of fluids, hemodilution decreases blood viscosity promot-
ing intrarenal shunting and heterogeneity with a de-
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creased capillary density and enhances microcirculatory 
cortex and medullary hypoxia. Hemodilution reduces re-
nal tissue oxygenation causing reduction in oxygen ex-
traction and ineffective sodium reabsorption associated 
with a loss of tubular polarity. In support of this notion, 
animal data suggest that blood transfusion may improve 
renal microvascular oxygenation and function superior to 
resuscitation with fluids [16] and improved microcircula-
tory perfusion in cardiosurgical patients [17].
Conclusion
AKI is a frequent complication in septic patients and 
optimization of fluid management is fundamental in or-
der to limit the detrimental role of fluids on renal me-
tabolism. In particular, during the first phases, fluid re-
suscitation should take into account the etiology of AKI, 
the volume status of the patients, the type of fluid, and its 
infusion rate. Finally, the lack of available tools at the bed-
side of patients able to provide information regarding re-
nal microcirculation, prevent from identifying therapeu-
tic target for fluid management specific for renal oxygen 
delivery optimization. Recent animal studies have shown 
that sublingual microcirculatory alterations closely fol-
low renal microcirculatory alterations in septic shock and 
during resuscitation, whereas systemic hemodynamic al-
terations that normalize during fluid resuscitation do not 
[18]. These results suggest that the identification of al-
terations in sublingual microcirculation may be used as a 
surrogate for renal microcirculatory alterations indicat-
ing a kidney at risk for developing AKI [19].
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